(Q48592300)

English

Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam.

scientific article published on 10 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17553501

Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17553501

elevated plus maze

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17553501

author name string

Lucas Albrechet-Souza

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17553501

Milene Cristina de Carvalho

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17553501

Celso Rodrigues Franci

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17553501

publication date

10 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17553501

Hormones and Behaviour

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17553501

52

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17553501

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17553501

267-273

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17553501

Long-lasting, selective, anxiogenic effects of feline predator stress in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Illumination has no effect on rats' behavior in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Effect of predatory stress on sucrose intake and behavior on the plus-maze in male mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Changes in the biogenic amine content of the prefrontal cortex, amygdala, dorsal hippocampus, and nucleus accumbens of rats submitted to single and repeated sessions of the elevated plus-maze test

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Sex differences in serotonergic activity in dorsal and median raphe nucleus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

"One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Raised corticosterone in the rat after exposure to the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Social condition affects hormone secretion and exploratory behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

5HT drugs in animal models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Responders and nonresponders to cat odor do not differ in other tests of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Arm width and brightness modulation of spontaneous behaviour of two strains of mice tested in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Chronic restraint or variable stresses differently affect the behavior, corticosterone secretion and body weight in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Role of resocialization and of 5-HT1A receptor activation on the anxiogenic effects induced by isolation in the elevated plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

"Over-all" hormonal balance as a key to endocrine organization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Behavioral specificity of non-genomic glucocorticoid effects in rats: effects on risk assessment in the elevated plus-maze and the open-field.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Anxiogenic stimuli in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2007.05.002

7 January 2021

Identifiers

10.1016/J.YHBEH.2007.05.002

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17553501

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17553501

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48592300&oldid=1370888048"